Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

Written By Yiran Gan
Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease - Chen et al. 2020

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson's Disease

Publication Date: 2020.04.29

Authors: NC Chen, HL Chen, SH Li, YH Chang, MH Chen, NW Tsai, CC Yu, SY Yang, CH Lu and WC Lin

Journal: Front. Aging Neurosci., 28 April 2020

© 2020 Chen, Chen, Li, Chang, Chen, Tsai, Yu, Yang, Lu and Lin

Frontiers in Aging Neuroscience

Yiran Gan
Previous

Plasma pyroglutamate‐modified amyloid beta differentiates amyloid pathology
Next

Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein over Repeated Freeze/Thaw Cycles